2024-03-28T15:11:01Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_65ACCD8023E1
2024-03-23T02:28:03Z
openaire
documents
urnserval
serval:BIB_65ACCD8023E1
Severity of COVID-19 in patients with lung cancer: evidence and challenges.
10.1136/jitc-2020-002266
000631525400011
33737345
Passaro
A.
author
Bestvina
C.
author
Velez Velez
M.
author
Garassino
M.C.
author
Garon
E.
author
Peters
S.
author
article
review
2021-03
Journal for immunotherapy of cancer
2051-1426
2051-1426
journal
9
3
e002266
Antineoplastic Agents/therapeutic use
COVID-19/complications
COVID-19/mortality
COVID-19/physiopathology
Carcinoma, Non-Small-Cell Lung/complications
Carcinoma, Non-Small-Cell Lung/therapy
China
Humans
Immune Checkpoint Inhibitors/therapeutic use
Italy
Lung Neoplasms/complications
Lung Neoplasms/therapy
Mortality
Netherlands
Pneumonectomy
Radiotherapy
Risk Factors
SARS-CoV-2
Severity of Illness Index
Small Cell Lung Carcinoma/complications
Small Cell Lung Carcinoma/therapy
United Kingdom
United States
COVID-19
lung neoplasms
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Review
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_65ACCD8023E1
https://serval.unil.ch/resource/serval:BIB_65ACCD8023E1.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_65ACCD8023E12
Creative Commons : Attribution-NonCommercial 4.0 International